PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the company will be participating in two upcoming virtual investor conferences. Details of the events are as follows:
Cowen 41st Annual Health Care Conference
Date: March 4, 2021
Time: 1:30 pm ? 2:30 pm ET
Chief Executive Officer, Jonathan P. Mow, is scheduled to participate in a panel discussion
H.C. Wainwright Global Life Sciences Conference
Date: March 9, 2021
Time: On demand beginning at 7:00 am ET
Chief Executive Officer, Jonathan P. Mow, will present a company overview
Interested parties can access the live and archived webcasts of the virtual sessions on the "Events and Presentations" page of the "Investors" section of the company's website at www.phasebio.com. The webcast replays will be available for 90 days after the conclusion of the live presentations.
About PhaseBio
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases. The company's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor; pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension; and PB6440, an oral agent for the treatment of resistant hypertension. PhaseBio's proprietary elastin-like polypeptide technology platform enables the development of therapies with potential for less-frequent dosing and improved pharmacokinetics, including pemziviptadil, and drives both internal and partnership drug-development opportunities.
PhaseBio is located in Malvern, PA, and San Diego, CA. For more information, please visit www.phasebio.com, and follow us on Twitter @PhaseBio and LinkedIn.
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...